CSF3 and Decreased total neutrophil count: Furthermore, leridistim (myelopoietin, a chimeric dual G-CSF and IL-3 receptor agonist) is not being developed as a countermeasure, despite promising initial results showing its efficacy in ameliorating severe, radiation-induced neutropenia within large, experimental animals (MacVittie et al., 2000).